09.22.10
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, has acquired Microbia, Inc., Lexington, MA, from Ironwood Pharmaceuticals, Inc. The terms of the acquisition will not be disclosed.
“The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes," explained Leendert Staal, president and CEO of DSM Nutritional Products. "This acquisition allows us to expand our product portfolio as well as our research and development capabilities.”
“We are thrilled to join DSM. Being part of a large global organization, and a world leader in industrial biotechnology, vitamins and carotenoid development, manufacturing and sales will expedite our ability to leverage our proprietary bio-based technology platform," added Kevin Madden, chief science officer of Microbia. "We look forward to help accelerate DSM’s ongoing efforts to develop, produce and commercialize the next generation of nutritional ingredients and other materials that will help the food, feed, chemicals and other industries produce more innovative and sustainable products, in a far more cost effective and responsible manner.”